arBtrage CAPITALIZING MARKETS checking… Sign in

Jasper Therapeutics, Inc.

JSPR Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.49
▲ +2.4% Today
as of Jun 7, 07:18 ET
Last 30 days -46.99% Apr 28 → Jun 05
$0.44 $0.59 $0.73 $0.88 $1.03 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.48
High
$0.50
Low
$0.47
Volume
$557,031
Avg Vol
$823,713
Mkt Cap
$25M
P/E (TTM)
Beta
52w High
$7.19
52w Low
$0.43
Div Yield
Shares Out
$28M

Overview

52-week range
$0.43
$7.19
1% of range
Avg surprise (last 2)
-1.6%
Avg reaction (last 2)
+4.6%
100% positive
Latest IV / EM
6301%
EM ±872.7% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.74$-1.40$-1.06$-0.72$-0.38 Actual $-1.47Actual $-1.60Actual $-1.03Actual $-0.97Actual $-1.24Actual $-1.41Est $-1.17Actual $-1.74Actual $-1.13Actual $-0.38Est $-0.46 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-27M$-20M$-14M$-8M$-1M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.38 $-0.46 +17.4% +73.0% +4.2% earnings
Tue Sep 30, 2025Sep 2025 $-1.13 financials
Mon Jun 30, 2025Jun 2025 $-1.74 financials
Mon May 12, 2025Mar/2025 $-1.41 $-1.17 -20.5% +4.9% earnings
Mon Sep 30, 2024Sep 2024 $-1.24 financials
Sun Jun 30, 2024Jun 2024 $-0.97 financials
Sun Mar 31, 2024Mar 2024 $-1.03 financials
Sat Sep 30, 2023Sep 2023 $-1.60 financials
Fri Jun 30, 2023Jun 2023 $-1.47 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$4M$9M$10M$9M
Gross profit
Operating income$-11M$-19M$-27M$-22M$-20M$-16M
Net income$-1M$-19M$-27M$-21M$-19M$-15M
EPS (diluted)$-0.04$-1.13$-1.74$-1.41$-1.24$-0.97

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$14M$29M$51M$40M$49M$72M$93M$107M
Inventory
Total current assets$20M$35M$55M$43M$53M$76M$95M$109M
Total assets$21M$36M$57M$46M$58M$80M$99M$114M
Long-term debt
Total liabilities$18M$32M$46M$23M$15M$18M$16M$14M
Total equity$3M$4M$12M$24M$42M$62M$84M$100M

Implied volatility — last 90 days

6295%6298%6300%6303%6305% Jun 07 — IV 6301% · EM ±872.7%

Sector peers